BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: He YC, Hao ZN, Li Z, Gao DW. Nanomedicine-based multimodal therapies: Recent progress and perspectives in colon cancer. World J Gastroenterol 2023; 29(4): 670-681 [PMID: 36742173 DOI: 10.3748/wjg.v29.i4.670]
URL: https://www.wjgnet.com/1007-9327/full/v29/i4/670.htm
Number Citing Articles
1
Qi Yu, Tongtong Wu, Wenhong Xu, Junyuan Wei, Anqi Zhao, Miaomiao Wang, Meiying Li, Guangfan Chi. PTBP1 as a potential regulator of diseaseMolecular and Cellular Biochemistry 2024; 479(11): 2875 doi: 10.1007/s11010-023-04905-x
2
Wentao Yuan, Xiaolin Zhang, Hui Cong. Advances in the protein‑encoding functions of circular RNAs associated with cancer (Review)Oncology Reports 2023; 50(2) doi: 10.3892/or.2023.8597
3
Sheikh Rezzak Ali, Chinmoyee Deori, Gaurab Kr Gogoi, Naba Jyoti Borah, Prajnyan Prasad Kalita, Rubina Chowdhury, Simran Kaur, Bibhuti Bhusan Kakoti. Liposomic nano particles in the treatment of colorectal and ovarian cancerEuropean Journal of Medicinal Chemistry Reports 2024; 11: 100149 doi: 10.1016/j.ejmcr.2024.100149
4
Daniel J. Lagal, Antonio M. Montes-Osuna, Alberto Ortiz-Olivencia, Candela Arribas-Parejas, Ángel Ortiz-Alcántara, Cristina Pescuezo-Castillo, José Antonio Bárcena, Carmen Alicia Padilla, Raquel Requejo-Aguilar. Tumoral Malignancy Decreases Coupled with Higher ROS and Lipid Peroxidation in HCT116 Colon Cancer Cells upon Loss of PRDX6Antioxidants 2024; 13(7): 881 doi: 10.3390/antiox13070881
5
Puja Sandbhor, Pranoti Palkar, Sakshi Bhat, Geofrey John, Jayant S. Goda. Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapyNanoscale 2024; 16(13): 6330 doi: 10.1039/D3NR06131K
6
Maria Shahzad, Huma Hameed, Ayesha Amjad, Mahtab Ahmad Khan, Inaba Shujaat Qureshi, Anam Hameed, Asad Saeed, Rabia Munir. An updated landscape on nanopharmaceutical delivery for mitigation of colon cancerNaunyn-Schmiedeberg's Archives of Pharmacology 2024;  doi: 10.1007/s00210-024-03482-0